REGENXBIO Inc. Other Non-Current Liabilities
REGENXBIO Inc. (RGNX) had Other Non-Current Liabilities of $486.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $486.00K.
- 2026-03-31: Other Liabilities, Noncurrent $622.00K.
- 2025-12-31: Other Liabilities, Noncurrent $638.00K.
- 2025-09-30: Other Liabilities, Noncurrent $648.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $486.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $622.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $638.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $648.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $664.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $680.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $3.63M 10-K · filed 2026-03-05 |
| 2024-09-30 | $3.58M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $3.53M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $3.48M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $6.25M 10-K · filed 2025-03-13 |
| 2023-09-30 | $6.19M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $6.08M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $5.98M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $8.83M 10-K · filed 2024-02-27 |
| 2022-09-30 | $8.66M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $8.53M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $7.68M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $745.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $484.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $514.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $448.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $524.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $545.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $582.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $672.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.83M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.84M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $1.90M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.77M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $2.50M 10-K · filed 2020-02-26 |
| 2018-09-30 | $691.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $720.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.78M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |